OncoResponse oncoresponseinc.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against novel immuno-oncology targets. By identifying candidates from the immune systems of patients who have responded exceptionally well to cancer immunotherapies, OncoResponse has the potential to increase the success rate of these therapies across multiple cancer types.

OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against novel immuno-oncology targets. By identifying candidates from the immune systems of patients who have responded exceptionally well to cancer immunotherapie...Show all

Company (Alive / Active)

Phone:

Fax:

909 Fannin Street
Suite 2100
Houston, 77024
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
OncoResponse $22.5M Mar 9, 2017
BeneVir Biopharm $10M May 2, 2018
Neon Therapeutics $161M Dec 5, 2017
See all 12 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related OncoResponse Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors
See all 12 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)